ReviewJournal of clinical orthopaedics and trauma2026
The role of genetics and molecular mechanisms in early onset scoliosis.
Review in Journal of clinical orthopaedics and trauma, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Early onset scoliosis (EOS), a spinal deformity that occurs before 10 years of age, imposes significant morbidity due to its rapid Cobb angle progression, three-dimensional spinal curvature, and potential respiratory compromise from thoracic cage distortion. This condition, classified into idiopathic, congenital, neuromuscular, and syndromic subtypes, exhibits high phenotypic heterogeneity and multisystem involvement. Current treatments like bracing and surgery focus on modulating curve progression and preserving growth, but the genetic and molecular overview is not clear. This review delineates both the genetic basis and the pathogenic mechanisms of EOS. We summarize 79 genes implicated in EOS subtypes and discuss the underlying pathogenetic mechanisms, including somitogenesis defects, abnormal vertebral development, and neuromuscular disorders. We also highlight emerging therapeutic strategies and discuss future directions. By integrating genetic discoveries with molecular pathophysiology, this review provides a foundation for advancing precision medicine in EOS and highlights critical future research directions in the field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.